References
Backhoff D, Muller M, Ruschewski W, Paul T, Krause U (2014) Icd therapy for primary prevention of sudden cardiac death after mustard repair for d-transposition of the great arteries. Clin Res Cardiol 103:894–901
Kolb C, Lennerz C, Semmler V, Jilek C (2013) Primary prevention of sudden cardiac death with an entirely subcutaneous defibrillator in a patient with a large right atrial thrombus. Clin Res Cardiol 102:169–170
Yamazawa H, Takeda A, Takei K, Furukawa T (2014) Primary prevention of sudden cardiac death in a low-risk child with familial hypertrophic cardiomyopathy: the role of cardiac magnetic resonance imaging. Clin Res Cardiol 103:75–77
Alcalde M, Campuzano O, Sarquella-Brugada G, Arbelo E, Allegue C, Partemi S, Iglesias A, Oliva A, Brugada J, Brugada R (2015) Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy. Clin Res Cardiol 104:288–303
Bobinger T, Kallmunzer B, Kopp M, Kurka N, Arnold M, Hilz MJ, Huttner HB, Schwab S, Kohrmann M (2015) Prevalence and impact on outcome of electrocardiographic early repolarization patterns among stroke patients: A prospective observational study. Clin Res Cardiol. doi:10.1007/s00392-015-0831-6
Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kaab S, Murgatroyd F, Reeve HL, Carter N, Boersma L (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the effortless S-ICD registry. Eur Heart J 35:1657–1665
Aziz S, Leon AR, El-Chami MF (2014) The subcutaneous defibrillator: a review of the literature. J Am Coll Cardiol 63:1473–1479
Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol 100:737–744
Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE (2012) The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 60:1933–1939
Jarman JW, Todd DM (2013) United kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. Europace 15:1158–1165
Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC (2013) Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 128:944–953
Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA (2010) An entirely subcutaneous implantable cardioverter-defibrillator. New Engl J Med 363:36–44
Porterfield C, DiMarco JP, Mason PK (2015) Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker. Am J Cardiol 115:276–278
Brisben AJ, Burke MC, Knight BP, Hahn SJ, Herrmann KL, Allavatam V, Mahajan D, Sanghera R, Gold MR (2015) A new algorithm to reduce inappropriate therapy in the s-icd system. J Cardiovasc Electrophysiol 26:417–423
Aydin A, Hartel F, Schluter M, Butter C, Kobe J, Seifert M, Gosau N, Hoffmann B, Hoffmann M, Vettorazzi E, Wilke I, Wegscheider K, Reichenspurner H, Eckardt L, Steven D, Willems S (2012) Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circulation Arrhythm Electrophysiol 5:913–919
Guenther M, Kolschmann S, Knaut M (2015) Substernal lead implantation: a novel option to manage DFT failure in S-ICD patients. Clin Res Cardiol 104:189–191
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
G.F., D.G.D., S.Z., J.K., L.E. and F.R. received travel grants and lecture honoraria from BIOTRONIK, Boston Scientific, Medtronic, Sorin Group and St. Jude Medical.
Rights and permissions
About this article
Cite this article
Frommeyer, G., Dechering, D.G., Zumhagen, S. et al. Limitations in S-ICD therapy: reasons for system explantation. Clin Res Cardiol 104, 902–907 (2015). https://doi.org/10.1007/s00392-015-0880-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-015-0880-x